Ophthalmology, Retina Specialist · El Paso, TX
NPI
1548587769
Since 2010
Specialty
Ophthalmology, Retina Specialist
Code 207WX0107X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1700 Curie Dr Ste 3800
El Paso, TX, 79902
Phone (915) 532-3912
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.5M
25,896 services
Medicare patients, 2024
708
Average age 77
Drug cost, 2024
$39K
454 prescriptions
Company payments, 2025
$3,749
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard Y Hwang was code J2777 (injection, faricimab-svoa, 0.1 mg), 14,160 times for 40 patients. In total Richard Y Hwang billed 25,896 services in 35 codes, and Medicare paid $2.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 14,160 | 40 | $27.29 | $386K |
| 92250 Angiography | Office | 2,066 | 665 | $28.99 | $60K |
| 92014 Ophthalmological E&M | Office | 1,947 | 624 | $97.46 | $190K |
| J0178 Injection, aflibercept, 1 mg | Office | 1,834 | 143 | $650.68 | $1.2M |
| 67028 Intravitreal Injection | Office | 1,473 | 311 | $103.44 | $152K |
| Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 1,193 | 62 | $175.93 | $210K |
| J2782 Injection, avacincaptad pegol, 0.1 mg | Office | 980 | 15 | $86.40 | $85K |
| J2778 Injection, ranibizumab, 0.1 mg | Office | 920 | 41 | $122.72 | $113K |
| 92235 Angiography | Office | 216 | 214 | $120.67 | $26K |
| 99204 Office E&M - New | Office | 179 | 179 | $124.55 | $22K |
| J7999 Compounded drug, not otherwise classified | Office | 177 | 67 | $75.30 | $13K |
| 92134 Computerized Ophthalmic Imaging | Office | 143 | 140 | $29.48 | $4,216 |
| 92201 Ophthalmological E&M | Office | 65 | 64 | $18.70 | $1,216 |
| J9035 Injection, bevacizumab, 10 mg | Office | 40 | 23 | $46.76 | $1,871 |
| 92242 Angiography | Office | 19 | 19 | $210.06 | $3,991 |
By year: 2022 $2.5M for 10,877 services; 2023 $2.6M for 18,458 services; 2024 $2.5M for 25,896 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richard Y Hwang prescribed most often to Medicare patients was Prednisolone Acetate, with 125 prescriptions and refills. In total Richard Y Hwang wrote 454 Medicare prescriptions that cost $39K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 125 | 183 | 103 | $6,090 |
| Moxifloxacin Moxifloxacin Hcl | 87 | 87 | 80 | $2,544 |
| Cyclopentolate Hcl Generic | 53 | 69 | 49 | $720 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 38 | 112 | 25 | $285 |
| Ketorolac Tromethamine Generic | 33 | 49 | 17 | $1,294 |
| Latanoprost Generic | 33 | 71 | 18 | $330 |
| Brimonidine Tartrate Generic | 17 | 37 | Under 11 | $1,615 |
| Timolol Maleate Generic | 14 | 29 | 11 | $115 |
Brand drugs: - claims; generic drugs: 276 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard Y Hwang $3,749 ($617 in general payments such as food, travel and fees and $3,132 for research) from 7 companies. The largest payer was Regeneron Pharmaceuticals, Inc. with $3,132.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.